Last reviewed · How we verify

NCT02459392: EPCSII

EuroPainClinics® Study II (Prospective Trial)

Completed NA Last updated 3 January 2022
What this trial tests

NA trial testing Epiduroscopy in Lumbar Spinal Stenosis in 300 participants. Completed in 31 December 2021.

Timeline
31 December 2021
Primary endpoint
31 December 2021
31 December 2021

Quick facts

Lead sponsorEPC Education s.r.o.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment300
Start date31 December 2021
Primary completion31 December 2021
Estimated completion31 December 2021
Sites1 location across Czechia

Drugs / interventions tested

Conditions studied

Sponsor

EPC Education s.r.o. — full company profile →

Who can join

18 and older, any sex, with Lumbar Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective multi-centre double-blind trial the effect of the epiduroscopy will be examined in (approximately 300) adult patients with low back pain pain caused by failed back surgery syndrome (FBSS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Epiduroscopy

Trials testing the same drug.

Other recruiting trials for Lumbar Spinal Stenosis

Currently open trials in the same condition.

Other EPC Education s.r.o. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02459392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing